- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
正处于反弹阶段。
- 长期趋势：
已有38家主力机构披露2026-06-30报告期持股数据，持仓量总计1.21亿股，占流通A股35.08%
- 波段诊断：
-
技术面诊股
诊断结果：7.8技术面打败了90%的股票
技术面评分前10的股票
近期的平均成本为6.52元。空头行情中，目前正处于反弹阶段，投资者可适当关注。
平均成本
近期的平均成本为6.52元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"6.52","date":1788249182,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑赢大盘，明显跑赢行业平均水平。
[{"date":"2026.09.02","stock":"-1.66","trade":"-1.10","ind":"-1.88"},{"date":"2026.09.01","stock":"0.45","trade":"1.18","ind":"-1.02"},{"date":"2026.08.31","stock":"0.00","trade":"-1.47","ind":"0.44"},{"date":"2026.08.28","stock":"-0.75","trade":"-0.76","ind":"-0.68"},{"date":"2026.08.27","stock":"1.06","trade":"1.37","ind":"1.50"},{"date":"2026.08.26","stock":"0.77","trade":"0.02","ind":"0.69"},{"date":"2026.08.25","stock":"3.32","trade":"2.42","ind":"-0.35"},{"date":"2026.08.24","stock":"-0.94","trade":"-2.88","ind":"-2.13"},{"date":"2026.08.21","stock":"-2.74","trade":"-3.66","ind":"0.87"},{"date":"2026.08.20","stock":"4.96","trade":"3.82","ind":"0.59"},{"date":"2026.08.19","stock":"-2.34","trade":"-2.08","ind":"-5.01"},{"date":"2026.08.18","stock":"-0.47","trade":"-0.60","ind":"-0.56"},{"date":"2026.08.17","stock":"1.90","trade":"0.71","ind":"2.44"},{"date":"2026.08.14","stock":"-0.63","trade":"-0.46","ind":"0.45"},{"date":"2026.08.13","stock":"-1.40","trade":"1.38","ind":"-0.87"},{"date":"2026.08.12","stock":"3.37","trade":"0.65","ind":"1.09"},{"date":"2026.08.11","stock":"0.65","trade":"0.17","ind":"-0.40"},{"date":"2026.08.10","stock":"2.31","trade":"1.23","ind":"0.04"},{"date":"2026.08.07","stock":"2.89","trade":"4.40","ind":"1.42"},{"date":"2026.08.06","stock":"0.17","trade":"0.12","ind":"-0.24"},{"date":"2026.08.05","stock":"-1.34","trade":"0.50","ind":"1.86"}]
广济药业,深证成指,化学制药指数
压力支撑
该股压力位为6.50元，支撑位为6.39元。
[{"text":"\u538b\u529b\u4f4d","value":"6.50","date":1788278400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"6.39","date":1788278400,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前正处于反弹阶段，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.7资金面打败了51%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：09月02日 20:30
| 机构今日流向(万元) | -2393.01 | 机构5日流向(万元) | -5896.51 |
| 机构10日流向(万元) | -14465.22 | 机构20日流向(万元) | -23000.71 |
机构持仓
2026-06-30 与 2025-12-31 相比，主力机构持仓量增加1274.48万股，其中基金净增仓7家，主力净增仓14家，有一定的中长期投资价值。
截止2026-06-30，共38家主力机构（基金32家，QFII4家，一般法人2家），持仓量总计12067.08万股，占流通A股35.08%
其中，基金持仓与2025-12-31相比：
增仓：9家 ，增持 215.18万股
减仓：2家 ，减持 5.01万股
新出现在主力名单中：22家 ，持有902.43万股
从主力名单中消失：8家 ，原持有93.38万股
其中，基金持仓与2025-12-31相比：
增仓：9家 ，增持 215.18万股
减仓：2家 ，减持 5.01万股
新出现在主力名单中：22家 ，持有902.43万股
从主力名单中消失：8家 ，原持有93.38万股
消息面诊股
诊断结果：6.1消息面打败了75%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 广济药业上半年实现营收3.12亿元 同比增长10%
2026-08-28 - 维生素B2销量提升，广济药业上半年亏损幅度收窄
2026-08-28 - 股东追踪|王松新进广济药业前十大流通股东
2026-08-27 - 广济药业：公司将于2026年9月15日召开2026
2026-08-27 - 财报速递：广济药业2026年半年度净亏损5794.
2026-08-30 - 广济药业：2026年上半年净利润亏损5794.51
2026-08-27 - 广济药业定增申请获深交所受理 尚需审核注册
2026-08-27 - 8月27日午间公告一览：广济药业2026年度向特定
2026-08-27 - 广济药业（截止2026年8月20日）股东人数为27
2026-08-21 - 广济药业（截止2026年8月10日）股东人数为27
2026-08-12
消息列表
| 一般消息 | 股东大会 | 临时股东大会 | 2026-08-28 |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-08-28 |
| 一般消息 | 重大事项 | 关联交易 | 2026-08-28 |
| 一般消息 | 重大事项 | 关联交易 | 2026-08-27 |
| 利好 | 业绩预告 | 预计减亏 | 2026-07-15 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2026-06-30 |
| 一般消息 | 重大事项 | 关联交易 | 2026-06-11 |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-04-25 |
| 一般消息 | 重大事项 | 关联交易 | 2026-04-25 |
| 一般消息 | 重大事项 | 关联交易 | 2026-04-21 |
| 一般消息 | 募资投向 | 公司购买资产 | 2026-03-13 |
| 一般消息 | 高管变动 | 个人原因 | 2026-01-27 |
| 重大利空 | 业绩预告 | 预计增亏 | 2026-01-27 |
| 一般消息 | 募资投向 | 公司出售资产 | 2026-01-10 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-12-31 |
| 一般消息 | 高管变动 | 因公司治理结构调整 | 2025-11-14 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-09-18 |
| 一般消息 | 重大事项 | 关联交易 | 2025-09-04 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 1条 | 1条 | 0条 |
行业面诊股
诊断结果：6.2行业面打败了71%的股票
化学制药行业最新资金流向
近10日来该行业走势不明显，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，接近大盘。
[{"date":"2026.09.02","price":"-1.88","value":"1.18"},{"date":"2026.09.01","price":"-1.02","value":"-1.47"},{"date":"2026.08.31","price":"0.44","value":"-0.76"},{"date":"2026.08.28","price":"-0.68","value":"1.37"},{"date":"2026.08.27","price":"1.50","value":"0.02"},{"date":"2026.08.26","price":"0.69","value":"2.42"},{"date":"2026.08.25","price":"-0.35","value":"-2.88"},{"date":"2026.08.24","price":"-2.13","value":"-3.66"},{"date":"2026.08.21","price":"0.87","value":"3.82"},{"date":"2026.08.20","price":"0.59","value":"-2.08"},{"date":"2026.08.19","price":"-5.01","value":"-0.60"},{"date":"2026.08.18","price":"-0.56","value":"0.71"},{"date":"2026.08.17","price":"2.44","value":"-0.46"},{"date":"2026.08.14","price":"0.45","value":"1.38"},{"date":"2026.08.13","price":"-0.87","value":"0.65"},{"date":"2026.08.12","price":"1.09","value":"0.17"},{"date":"2026.08.11","price":"-0.40","value":"1.23"},{"date":"2026.08.10","price":"0.04","value":"4.40"},{"date":"2026.08.07","price":"1.42","value":"0.12"},{"date":"2026.08.06","price":"-0.24","value":"0.50"},{"date":"2026.08.05","price":"1.86","value":"2.05"}]
深证成指,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 神奇制药 | 103.24% | -4.83% | 5.3分 |
| 2 | 誉衡药业 | 55.14% | 9.42% | 6.5分 |
| 3 | 东亚药业 | 40.95% | 16.67% | 5.2分 |
| 4 | 哈药股份 | 36.48% | 12.96% | 6.4分 |
| 5 | 冀衡医药 | 34.49% | -2.33% | 5.0分 |
| 6 | - | 27.28% | 8.31% | 分 |
| 8 | 科源制药 | 22.81% | 1.45% | 5.6分 |
| 10 | 盟科药业 | 21.87% | 6.75% | 6.3分 |
| 12 | ST天圣 | 19.17% | 9.84% | 5.7分 |
| 14 | 西点药业 | 18.05% | -20.81% | 4.6分 |
| 16 | 石药创新 | 17.11% | -2.20% | 6.6分 |
| 18 | 赛托生物 | 15.79% | 8.56% | 5.9分 |
| 20 | 海森药业 | 14.30% | 1.81% | 6.2分 |
| 22 | 莎普爱思 | 11.68% | 1.54% | 6.0分 |
| 24 | 莱美药业 | 10.52% | -4.95% | 5.4分 |
| 26 | 亨迪药业 | 10.14% | -8.22% | 4.8分 |
| 28 | - | 9.98% | -3.05% | 分 |
| 30 | - | 9.39% | 6.11% | 分 |
| 32 | 易明医药 | 8.85% | 3.88% | 6.3分 |
| 34 | 威尔药业 | 8.59% | -1.62% | 4.8分 |
| 36 | 迪哲医药 | 8.13% | -0.78% | 5.5分 |
| 38 | 北大医药 | 7.79% | 0.35% | 5.0分 |
| 40 | 复旦张江 | 7.47% | -3.12% | 5.0分 |
| 42 | 金石亚药 | 7.16% | -2.82% | 5.2分 |
| 44 | 亚太药业 | 7.07% | -1.98% | 4.8分 |
| 46 | - | 6.94% | 8.40% | 分 |
| 48 | 华仁药业 | 6.67% | -0.69% | 5.6分 |
| 50 | ST南新 | 6.19% | 4.73% | 5.0分 |
| 52 | 花园生物 | 5.93% | 0.00% | 4.6分 |
| 54 | 金陵药业 | 5.85% | 0.60% | 5.3分 |
| 56 | 双鹭药业 | 5.58% | -3.66% | 5.3分 |
| 58 | 汇宇制药 | 5.17% | -3.49% | 5.1分 |
| 60 | 浙江医药 | 4.87% | -2.83% | 4.7分 |
| 62 | 鲁抗医药 | 4.77% | 3.92% | 5.9分 |
| 64 | 石药景峰 | 4.67% | -0.46% | 5.4分 |
| 66 | 向日葵 | 4.35% | 1.30% | 4.5分 |
| 68 | 海思科 | 4.23% | 2.67% | 7.0分 |
| 70 | 天宇股份 | 3.67% | 0.55% | 5.1分 |
| 72 | 民生健康 | 3.53% | -1.49% | 5.0分 |
| 74 | 泽璟制药 | 3.04% | -5.00% | 5.4分 |
| 76 | 海普瑞 | 2.68% | -4.13% | 5.4分 |
| 78 | 康芝药业 | 2.44% | -0.15% | 5.5分 |
| 80 | ST诺泰 | 2.19% | 3.53% | 5.5分 |
| 82 | 同和药业 | 1.91% | 0.14% | 5.3分 |
| 84 | - | 1.83% | -0.79% | 分 |
| 86 | 奥翔药业 | 1.80% | -1.49% | 4.7分 |
| 88 | 金城医药 | 1.75% | -0.22% | 5.2分 |
| 90 | 华邦健康 | 1.36% | -1.54% | 5.5分 |
| 92 | 九典制药 | 0.91% | -2.63% | 4.5分 |
| 94 | 华北制药 | 0.63% | -2.04% | 5.1分 |
| 96 | 海翔药业 | 0.37% | 4.22% | 5.5分 |
| 98 | 哈三联 | 0.16% | -6.53% | 4.6分 |
| 100 | 华特达因 | -0.47% | 4.37% | 4.9分 |
| 102 | 健友股份 | -0.75% | -1.36% | 5.1分 |
| 104 | ST惠程 | -1.05% | -5.29% | 5.5分 |
| 106 | 华润双鹤 | -1.30% | -1.48% | 5.6分 |
| 108 | 亚虹医药 | -1.77% | 3.40% | 5.6分 |
| 110 | 新天地 | -1.93% | -2.77% | 5.2分 |
| 112 | 普洛药业 | -2.10% | 3.33% | 5.9分 |
| 114 | 力生制药 | -2.36% | -0.70% | 4.8分 |
| 116 | 科伦药业 | -2.68% | -4.33% | 5.2分 |
| 118 | 华东医药 | -2.83% | -0.66% | 5.6分 |
| 120 | 川宁生物 | -3.08% | -4.07% | 4.4分 |
| 122 | 复星医药 | -3.27% | -2.89% | 5.1分 |
| 124 | 广生堂 | -3.33% | -5.22% | 4.2分 |
| 126 | 亿帆医药 | -4.11% | -2.10% | 5.0分 |
| 128 | 华海药业 | -4.14% | -2.62% | 5.0分 |
| 130 | 罗欣药业 | -4.33% | 0.21% | 5.0分 |
| 132 | 溢多利 | -5.25% | -11.53% | 4.3分 |
| 134 | 灵康药业 | -5.42% | -1.28% | 5.8分 |
| 136 | 美诺华 | -6.06% | -0.99% | 4.6分 |
| 138 | 泰恩康 | -6.81% | -0.58% | 5.6分 |
| 140 | 共同药业 | -7.12% | -1.85% | 4.5分 |
| 142 | 宏源药业 | -7.32% | -12.75% | 4.1分 |
| 144 | 信立泰 | -8.41% | -1.78% | 5.3分 |
| 146 | 微芯生物 | -9.07% | -3.42% | 4.8分 |
| 148 | 前沿生物 | -9.57% | -10.47% | 4.3分 |
| 150 | 新和成 | -10.57% | 0.72% | 4.8分 |
| 152 | 百利天恒 | -12.55% | -5.81% | 5.0分 |
| 154 | 常山药业 | -12.79% | -2.93% | 4.2分 |
| 156 | 恒瑞医药 | -14.89% | -2.50% | 5.4分 |
| 158 | 贝达药业 | -19.68% | -1.14% | 4.8分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2026-06-30 ]公司经营
盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 138/214 ， 128/214。
[{"date":"2026-06-30","value":"-9.26","vol":"-0.16"},{"date":"2026-03-31","value":"-4.95","vol":"0.45"},{"date":"2025-12-31","value":"-47.07","vol":"-1.85"},{"date":"2025-09-30","value":"-9.58","vol":"1.60"},{"date":"2025-06-30","value":"-7.36","vol":"1.26"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
-9.26 | -4.95 | -47.07 | -9.58 | -7.36 |
| 行业(%) | -0.16 | 0.45 | -1.85 | 1.60 | 1.26 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"23.25","vol":"49.70"},{"date":"2026-03-31","value":"22.44","vol":"50.98"},{"date":"2025-12-31","value":"26.57","vol":"49.96"},{"date":"2025-09-30","value":"29.40","vol":"49.79"},{"date":"2025-06-30","value":"30.38","vol":"49.69"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
23.25 | 22.44 | 26.57 | 29.40 | 30.38 |
| 行业(%) | 49.70 | 50.98 | 49.96 | 49.79 | 49.69 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 47/214 ， 52/214。
[{"date":"2026-06-30","value":"9.71","vol":"20.52"},{"date":"2026-03-31","value":"9.84","vol":"24.44"},{"date":"2025-12-31","value":"-2.32","vol":"38.58"},{"date":"2025-09-30","value":"-7.12","vol":"142.64"},{"date":"2025-06-30","value":"-4.08","vol":"79.18"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
9.71 | 9.84 | -2.32 | -7.12 | -4.08 |
| 行业(%) | 20.52 | 24.44 | 38.58 | 142.64 | 79.18 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"23.27","vol":"371.05"},{"date":"2026-03-31","value":"12.75","vol":"52.58"},{"date":"2025-12-31","value":"-36.98","vol":"-24.51"},{"date":"2025-09-30","value":"38.64","vol":"3.72"},{"date":"2025-06-30","value":"29.19","vol":"66.32"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
23.27 | 12.75 | -36.98 | 38.64 | 29.19 |
| 行业(%) | 371.05 | 52.58 | -24.51 | 3.72 | 66.32 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 105/214 ， 94/214。
[{"date":"2026-06-30","value":"0.14","vol":"0.21"},{"date":"2026-03-31","value":"0.07","vol":"0.10"},{"date":"2025-12-31","value":"0.24","vol":"0.41"},{"date":"2025-09-30","value":"0.16","vol":"0.31"},{"date":"2025-06-30","value":"0.10","vol":"0.21"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.14 | 0.07 | 0.24 | 0.16 | 0.10 |
| 行业(次) | 0.21 | 0.10 | 0.41 | 0.31 | 0.21 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.94","vol":"1.27"},{"date":"2026-03-31","value":"0.54","vol":"0.64"},{"date":"2025-12-31","value":"1.58","vol":"2.56"},{"date":"2025-09-30","value":"0.95","vol":"1.94"},{"date":"2025-06-30","value":"0.59","vol":"1.30"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.94 | 0.54 | 1.58 | 0.95 | 0.59 |
| 行业(次) | 1.27 | 0.64 | 2.56 | 1.94 | 1.30 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 102/214 ， 4/214。
[{"date":"2026-06-30","value":"7.36","vol":"4.52"},{"date":"2026-03-31","value":"20.09","vol":"-2.75"},{"date":"2025-12-31","value":"6.57","vol":"16.48"},{"date":"2025-09-30","value":"15.44","vol":"4.59"},{"date":"2025-06-30","value":"19.02","vol":"2.93"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 7.36 | 20.09 | 6.57 | 15.44 | 19.02 |
| 行业 | 4.52 | -2.75 | 16.48 | 4.59 | 2.93 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.07","vol":"1.32"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.22","vol":"1.60"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.29","vol":"1.72"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 0.07 | - | 0.22 | - | 0.29 |
| 行业 | 1.32 | 0.00 | 1.60 | 0.00 | 1.72 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 98/214 ， 76/214。
[{"date":"2026-06-30","value":"0.53","vol":"3.49"},{"date":"2026-03-31","value":"0.62","vol":"3.58"},{"date":"2025-12-31","value":"0.61","vol":"3.33"},{"date":"2025-09-30","value":"0.67","vol":"3.50"},{"date":"2025-06-30","value":"0.77","vol":"3.68"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
0.53 | 0.62 | 0.61 | 0.67 | 0.77 |
| 行业 | 3.49 | 3.58 | 3.33 | 3.50 | 3.68 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.32","vol":"2.80"},{"date":"2026-03-31","value":"0.42","vol":"2.94"},{"date":"2025-12-31","value":"0.39","vol":"2.71"},{"date":"2025-09-30","value":"0.36","vol":"2.75"},{"date":"2025-06-30","value":"0.49","vol":"2.90"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
0.32 | 0.42 | 0.39 | 0.36 | 0.49 |
| 行业 | 2.80 | 2.94 | 2.71 | 2.75 | 2.90 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 77/214 ， 6/214。
[{"date":"2026-06-30","value":"74.01","vol":"33.54"},{"date":"2026-03-31","value":"74.12","vol":"33.40"},{"date":"2025-12-31","value":"72.89","vol":"34.57"},{"date":"2025-09-30","value":"62.67","vol":"34.00"},{"date":"2025-06-30","value":"66.50","vol":"34.11"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
74.01 | 74.12 | 72.89 | 62.67 | 66.50 |
| 行业(%) | 33.54 | 33.40 | 34.57 | 34.00 | 34.11 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"2.70","vol":"0.71"},{"date":"2026-03-31","value":"2.73","vol":"9.83"},{"date":"2025-12-31","value":"2.58","vol":"1.77"},{"date":"2025-09-30","value":"1.68","vol":"1.19"},{"date":"2025-06-30","value":"1.99","vol":"0.88"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
2.70 | 2.73 | 2.58 | 1.68 | 1.99 |
| 行业(%) | 0.71 | 9.83 | 1.77 | 1.19 | 0.88 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2026年的收益，请投资者后续关注。
[{"date":"2022","yellowRectValue":"0.50","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-1.40","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-2.95","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"-4.04","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]